2024
Mixed-field ABO front typing as an early sign of disease recurrence in ABO-matched stem cell transplantation
Yurtsever N, Lee E, Pinatti L, Shah B, Tormey C, Siddon A. Mixed-field ABO front typing as an early sign of disease recurrence in ABO-matched stem cell transplantation. Immunohematology 2024, 40: 89-92. PMID: 39373301, DOI: 10.2478/immunohematology-2024-013.Peer-Reviewed Original ResearchMeSH KeywordsABO Blood-Group SystemAgedBlood Grouping and CrossmatchingFemaleHematopoietic Stem Cell TransplantationHumansRecurrenceStem Cell TransplantationTransplantation, HomologousConceptsStem cell transplantationCell transplantationDisease recurrenceMyeloid neoplasmsChimerism testingAllogeneic stem cell transplantationSigns of disease recurrenceIndicator of disease recurrenceDonor-recipient pairsABO antigen expressionGraft statusAntigen expressionFemale patientsPost-transplantationAllograft statusTransplantationABO typeRecurrenceClinical settingEarly signsNeoplasmsChimerismEarly indicatorABOEngraftment
2021
Autologous hematopoietic stem cell product contaminated with Salmonella due to occult salmonellosis in an asymptomatic donor
Jacobs JW, Guarente J, Hendrickson JE, Tormey CA, Bar N. Autologous hematopoietic stem cell product contaminated with Salmonella due to occult salmonellosis in an asymptomatic donor. Journal Of Clinical Apheresis 2021, 37: 316-319. PMID: 34953078, DOI: 10.1002/jca.21962.Peer-Reviewed Original ResearchMeSH KeywordsHematopoietic Stem Cell TransplantationHematopoietic Stem CellsHumansSalmonellaSalmonella InfectionsTransplantation, AutologousConceptsCellular therapy productsHematopoietic stem cellsAllogeneic blood productsAutologous hematopoietic stem cellsHematopoietic stem cell productsPathogenic Gram-negative organismsNormal skin floraTherapy productsCase of SalmonellaStem cell productsGram-negative organismsAsymptomatic donorsTherapeutic dilemmaBlood productsPathogen reduction technologySkin floraHSC productsAdverse effectsCell productsPrior reportsSignificant reductionStem cellsSalmonellosisSalmonella bacteriaMost microorganismsTransfusion practices for pediatric oncology and hematopoietic stem cell transplantation patients: Data from the National Heart Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study‐III (REDS‐III)
Goel R, Nellis ME, Karam O, Hanson SJ, Tormey CA, Patel RM, Birch R, Sachais BS, Sola‐Visner M, Hauser RG, Luban NLC, Gottschall J, Josephson CD, Hendrickson JE, Karafin MS, Study‐IV‐Pediatric F. Transfusion practices for pediatric oncology and hematopoietic stem cell transplantation patients: Data from the National Heart Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study‐III (REDS‐III). Transfusion 2021, 61: 2589-2600. PMID: 34455598, DOI: 10.1111/trf.16626.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentBlood DonorsBlood TransfusionChildChild, PreschoolErythrocyte TransfusionFemaleHematopoietic Stem Cell TransplantationHumansInfantMaleNeoplasmsPediatricsPlatelet TransfusionRetrospective StudiesConceptsInternational normalized ratioBlood Institute Recipient EpidemiologyDonor Evaluation Study-IIINational Heart LungTransfusion practicePediatric oncologyRecipient EpidemiologyHSCT patientsPlasma transfusionRed blood cellsPlatelet countHeart LungHematopoietic stem cell transplantation patientsHematopoietic stem cell transplant patientsMedian international normalized ratioStem cell transplant patientsStem cell transplantation patientsLower INR valuesPre-transfusion HbMedian platelet countMulticenter retrospective studyCell transplant patientsCell transplantation patientsStudy IIIAcute myeloid leukemia
2008
Mobilization, collection, and transplantation of peripheral blood hematopoietic progenitor cells in a patient with multiple myeloma and hemoglobin SC disease
Tormey CA, Snyder EL, Cooper DL. Mobilization, collection, and transplantation of peripheral blood hematopoietic progenitor cells in a patient with multiple myeloma and hemoglobin SC disease. Transfusion 2008, 48: 1930-1933. PMID: 18513256, DOI: 10.1111/j.1537-2995.2008.01777.x.Peer-Reviewed Original ResearchMeSH KeywordsBlood Component RemovalErythrocyte TransfusionFemaleHematopoietic Stem Cell MobilizationHematopoietic Stem Cell TransplantationHemoglobin SC DiseaseHumansMiddle AgedMultiple MyelomaConceptsHigh-dose G-CSFHemoglobin SC diseaseHematopoietic progenitor cellsHPC mobilizationVasoocclusive crisisSC diseaseG-CSFVasoocclusive complicationsAutologous stem cell transplantationAutologous hematopoietic progenitor cellsPeripheral blood hematopoietic progenitor cellsBlood hematopoietic progenitor cellsProgenitor cellsStem cell transplantationG-CSF administrationG-CSF mobilizationPosttransplant periodMyeloablative chemotherapyCell transplantationMultiple myelomaErythrocytapheresisPatientsCell engraftmentComplicationsBlood harvesting